机构:[1]Division of Cardiology and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China内科系统心血管内科华中科技大学同济医学院附属同济医院[2]Department of Cardiology, China-Japan Friendship Hospital, Beijing, China[3]Emergency and Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China临床科室急诊危重症中心首都医科大学附属安贞医院[4]Stephenson Cancer Center and Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma, OK, USA
All animal experiments were approved by the Institutional Animal Research Committee of Tongji Medical College and complied with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health. Male C57BL/6 mice (22–25 g) were obtained from the Model Animal Research Center of Nanjing University (Nanjing, China). Mice were housed at the animal care facility of Tongji Medical College with 12-hour light/12-hour dark cycles and free access to water and food. Mice were subjected to thoracic aorta constriction (TAC) or the same operation without aortic constriction for 4 weeks, as described previously [54]. C57BL/6 mice were continuously infused with Ang II (1.5 mg/kg/day, Sigma-Aldrich China Inc., Shanghai, China) with implanted mini-osmotic pumps (Alzet model 1004; DURECT Corp., Cupertino, CA) over a period of 28 days. C57BL/6 mice were randomly divided into different groups (n > 7 per group), as follows: Control, Ang II, Ang II + rAAV-GFP, Ang II + rAAV-miR-124, Ang II + rAAV-miR-124 TuDs, and Ang II + rAAV-miR-124 + rAAV-CD151.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|2 区医学
小类|2 区肿瘤学3 区细胞生物学
最新[2025]版:
无
第一作者:
第一作者机构:[1]Division of Cardiology and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[1]Division of Cardiology and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
推荐引用方式(GB/T 7714):
Yanru Zhao,Mengwen Yan,Chen Chen,et al.MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart[J].Oncotarget.2018,9(18):14382-14396.doi:10.18632/oncotarget.24205.
APA:
Yanru Zhao,Mengwen Yan,Chen Chen,Wei Gong,Zhongwei Yin...&Houjuan Zuo.(2018).MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart.Oncotarget,9,(18)
MLA:
Yanru Zhao,et al."MiR-124 aggravates failing hearts by suppressing CD151-facilitated angiogenesis in heart".Oncotarget 9..18(2018):14382-14396